Brosious, Effie M., and Schmidt, Robert M.: Quantitation of hemoglobin F. An interlaboratory study. Am J Clin Pathol 72: [421] [422] [423] [424] [425] 1979 . Samples of whole blood from four hematologically normal adults and from two individuals with increased fetal hemoglobin levels were shipped to laboratories participating in the 1976 and 1977 Center for Disease Control (CDC) hemoglobinopathy proficiency testing surveys. The data from these surveys were used to evaluate the interlaboratory variability of current methods used to quantitate hemoglobin F (Hb F). Results of Hb F quantitation obtained from more than 100 laboratories that voluntarily participated in the survey were compared with those obtained from 21 reference laboratories. Individual values for all samples varied greatly among laboratories and among methods. Results returned by most of the laboratories were outside two standard deviations of the reference laboratory mean • and were not accurate enough to differentiate between a normal level and an increased, abnormal level. (Key words: Hemoglobin F (Hb F); Proficiency testing; Quantitation of Hb F; Interlaboratory trial; Hemoglobinopathy; Fetal hemoglobin.) MANY ARTICLES reporting increased levels of fetal hemoglobin (Hb F) in the bloods of individuals with various hematologic abnormalities have appeared during the last five years.• •4,5,12,19,25,32-35 The normal adult level is generally considered to be less than 2.0%. 3, 9, 11, 29 Hb F is elevated in some malignancies, anemias, chronic renal disease, and thalassemia, as well as some benign conditions such as hereditary persistence of fetal hemoglobin (HPFH).
The latter condition is known to protect an individual who has hemoglobin S (sickle cell) against crises and severe disease when the HPFH is present with the sickle cell hemoglobin. Much confusion currently exists with regard to HPFH because many forms have been found to exist. 13>27,28,30,31 The different forms vary in the percentages of Hb F found and also in the distribution of Hb F within the erythrocyte. The methods that have been used to determine the levels of Hb F in these reports have varied, and several methods are in use today.
6_8,5_I5,21_24, 26, 37 Physicians frequently request determination of the levels of fetal hemoglobin for patients who have hemoglobinopathies or chronic anemia, as part of the total clinical evaluation of the patients. Since only slight elevations of Hb F occur with some types of malignancies, anemias, and thalassemias, accuracy in determining the level of Hb F is important in differentiating between samples with normal and elevated levels.
Methods
Whole blood was collected into citrate-phosphatedextrose (CPD) anticoagulated Fenwal® bags. Each original 450-ml blood sample was diluted with 100 ml of Alsever's solution, mixed well, and dispensed into 1.2-ml aliquots in 2-ml Wheaton vials, which were capped, sealed, and shipped in packages refrigerated with a cold pack. Participating laboratories (located in all 50 states) each received two samples quarterly during 1976 and 1977.
During 1976, one hematological^ and electrophoretically normal blood sample was shipped in each quarterly shipment. In the 1977 shipments, one sample having a normal Hb F level, obtained from a person who had sickle cell trait (A/S), was paired with a sample having a greatly elevated Hb F level, from a person with sickle cell-HPFH (S/HPFH); and one sample having a normal Hb F level, obtained from a person who had Hb D trait (A/D), was paired with one having a slightly elevated Hb F level, from a person with betathalassemia trait (A//3-thal).
Laboratories were asked to process and test the Standard deviations (SD) and coefficients of variation (CV) for volunteer laboratories were more than twice those of the reference laboratories for the 1977 surveys ( Table 1) . Results of Hb F quantitation by all laboratories for these four 1977 samples (two sample sets/shipment) are shown in Figure 1 . Figures 2 and 3 show Youden plots 36 of volunteer and reference laboratory results for each of the two specimen sets. Lines demarcating the reference mean ± 2 SD for the elevated Hb F level samples and + 2 SD for the normal level samples are drawn on the scattergram. Results from 34.5% of laboratories were outside these reference laboratory limits (center rectangle) for the S/HPFH-A/S specimen set, and 56% were outside these limits for the A/D-A//3-thal specimen set. Comparison of participant results by method (Table  2) indicates that densitometry generally gave higher CV values for each sample than did the other methods. Table 3 (Fig. 4) . Better results were achieved in differentiating the low level Hb F values (A/S sample) from the greatly elevated Hb F values (S/HPFH sample) (Fig. 5) .
Discussion
In agreement with the findings of White and Lewis with regard to the standardization of technics for Hb F quantitation in England, 34 we have found that the interlaboratory quantitation of this minor normal hemoglobin is a major problem. The technics used by most laboratories (i.e., the Singer and Betke methods) are relatively difficult to perform. Densitometry, while simpler to perform, has been previously reported to be unreliable for normal or low values of Hb F. 21 That the "normaP'-level sample could not be distinguished from the "slightly elevated"-level sample (the A/D-A//3-thal sample set) by any method in some laboratories supports the need for improvement in quality control procedures and further evaluation of methods for Hb F quantitation.
A previous evaluation of hemoglobinopathy interlaboratory trials in this country identified major problems in detecting and correctly interpreting abnormal hemoglobin patterns. 20 The error made most often in that study was one of improper interpretation of results. Most errors in results reported from laboratories in these 1976 and 1977 surveys, however, were probably a consequence of variable methodology and a lack of standardization of methods used to quantitate Hb F.
Either better methods or ways of standardizing the current methods are needed. Although they may cost more than conventional tests now in use, the immunologic methods may provide rapid, accurate and simple Hb F determinations. 816, 37 One manufacturer is preparing to market an immunologic kit, and premarketing evaluations are under way. 10 Chromatographic procedures are also promising. laboratory to determine their accuracies and precisions; the immunologic methods will be studied as they become commercially available.
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